Aurorix 150 mg film - coated tablets
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
09-05-2023
Karatteristiċi tal-prodott
(SPC)
09-05-2023
Ingredjent attiv:
Моклобемид
Disponibbli minn:
Meda Pharma GmbH & Co. KG
Kodiċi ATC:
N06AG2
INN (Isem Internazzjonali):
Moclobemide
Dożaġġ:
150 mg film - coated tablets
Sommarju tal-prodott:
Aurorix, 150 mg film - coated tablets x 30
Data ta 'l-awtorizzazzjoni:
2014-09-02
